4//SEC Filing
Kamal Mostafa 4
Accession 0001209191-20-058122
CIK 0000019411other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 6:33 PM ET
Size
9.0 KB
Accession
0001209191-20-058122
Insider Transaction Report
Form 4
Kamal Mostafa
CEO, Magellan Rx Management
Transactions
- Exercise of In-Money
Ordinary Common Stock, $0.01 par value
2020-11-10$66.57/sh+6,000$399,420→ 11,617 total - Sale
Ordinary Common Stock, $0.01 par value
2020-11-10$81.57/sh−6,000$489,420→ 5,617 total - Exercise of In-Money
Stock Option (right to buy)
2020-11-10−6,000→ 34,808 totalExercise: $66.57Exp: 2029-03-05→ Common Stock (6,000 underlying)
Footnotes (3)
- [F1]This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- [F2]Of the 13,603 stock options that vested on March 5, 2020, 7,603 remain available to exercise after the reported transaction. The remainder of 27,205 options shall vest in equal increments on March 3, 2021 and 2022.
- [F3]Not applicable.
Documents
Issuer
MAGELLAN HEALTH INC
CIK 0000019411
Entity typeother
Related Parties
1- filerCIK 0001647234
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 6:33 PM ET
- Size
- 9.0 KB